Oncogenes y Dianas Efectoras
PANCCUN
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von AstraZeneca (United Kingdom) (1)
2019
-
Identification of resistance pathways specific to malignancy using organoid models of pancreatic cancer
Clinical Cancer Research, Vol. 25, Núm. 22, pp. 6742-6755